期刊文献+

低密度脂蛋白胆固醇达标的冠心病患者餐后残粒脂蛋白-胆固醇水平及与冠脉病变严重程度相关性的研究 被引量:4

Study on the relationship between postprandial remnant-like particle cholesterol(RLP-C) level and the severity of coronary artery lesion in patients with normal low density lipoprotein cholesterol
下载PDF
导出
摘要 目的观察低密度脂蛋白胆固醇(LDL-C)达标的冠状动脉粥样硬化性心脏病(冠心病)患者餐后残粒脂蛋白-胆固醇(RLP-C)水平,并探讨其与冠状动脉病变严重程度的关系。方法连续入选2015年3月~2015年9月南京市胸科医院心内科收治的临床诊断为冠心病且低密度脂蛋白(LDL)达标的住院患者42例。按冠状动脉造影结果分为冠心病组及对照组,入院第2 d检查空腹及早餐后4 h的血脂水平:总胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白胆固醇(HDL-C)、LDL-C,使用公式法(RLPC=TC-HDL-C-LDL-C)计算得到RLP-C浓度,比较组间差异,并计算冠心病组冠状动脉病变Gensini评分,分析其与RLP-C的关系。结果两组空腹情况下TG、TC、LDL-C、RLP-C比较差异无统计学意义(P均>0.05);对照组HDL-C高于冠心病组,差异具有统计学意义(P<0.05)。两组餐后4 h情况下TG、TC、LDL-C比较差异无统计学意义(P均>0.05);冠心病组RLP-C高于对照组,对照组HDL-C仍高于冠心病组,差异均具有统计学意义(P<0.05)。冠心病组RLP-C增幅明显高于对照组,对照组HDL-C增幅高于冠心病组,差异均具有统计学意义(P<0.05)。分析空腹、餐后4 h各个血脂指标以及血脂指标增幅和Gensini评分之间的相关性,RLP-C的餐后增幅与Gensini评分具有中度相关性(r=0.450,P<0.05)。结论餐后RLP-C能够更好反应冠心病患者血脂水平及血脂相关性心血管剩留风险。 Objective To investigate postprandial remnant-like particle cholesterol(RLP-C)level in coronary heart disease(CHD)patients with normal low density lipoprotein cholesterol(LDL-C),and the relationship between RLP-C and the severity of coronary artery lesion.Methods42CHD patients with normal LDL-C in Nanjing Chest Hospital were recruited from March2015to September2015and divided into CHD group and control group according to coronary angiography.The levels of total cholesterol(TC),triglyceride(TG),high density lipoprotein cholesterol(HDL-C)and low density lipoprotein cholesterol(LDL-C)were measured4hours fasting and after breakfast.RLP-C level was calculated by the equation(RLP-C=TC-HDL-C-LDL-C).The Gensini score of coronary artery disease was calculated and the relationship with RLP-C was analyzed.Results There was nosignificant difference in TG,TC,LDL-C and RLP-C between the two groups(P>0.05).HDL-C in the control group was higher than that in the CHD group,the difference was statistically significant(P<0.05).There was no significant difference in TG,TC and LDL-C between the two groups at4hours postprandial(P>0.05).The level of RLP-C in CHD group was higher than that in control group,and HDL-C in control group was higher than that in CHD group(P<0.05).The increase of RLP-C in CHD group was significantly higher than that in control group,and the increase of HDL-C in control group was higher than that in CHD group(P<0.05).The postprandial increase of RLP-C was moderately correlated with the Gensini score(r=0.450,P<0.05).Conclusion RLP-C was a better index for the lipid level and the lipid-associated cardiovascular risk to CHD patients.
作者 李益民 王治 陆治平 李翔宇 陈锁芹 黄进 LI Yi-min;WANG Zhi;LU Zhi-ping;LI Xiang-yu;CHEN Suo-qin;HUANG Jin
出处 《中国循证心血管医学杂志》 2017年第4期467-469,共3页 Chinese Journal of Evidence-Based Cardiovascular Medicine
关键词 残粒脂蛋白-胆固醇 餐后状态 冠心病 Remnant-like particle cholesterol Postprandial period Coronary heart disease
  • 相关文献

参考文献2

二级参考文献65

  • 1中国心脏调查组,胡大一,潘长玉.中国住院冠心病患者糖代谢异常研究——中国心脏调查[J].中华内分泌代谢杂志,2006,22(1):7-10. 被引量:470
  • 2中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5228
  • 3Delahoy PJ, Magliano D J, Webb K, et al. The relationship between reduction in low-density lipoprotein cholesterol by statins and reduction in risk of cardiovascular outcomes : an updated meta- analysis. Clin Ther, 2009,31:236-244.
  • 4LaRosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Ene_l .1 Med. 2005.352 : 1425-1435.
  • 5Gaede P, Lund-Andersen H, Parving HH, et al. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med, 2008,358:580-591.
  • 6Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med, 1996,335:1001-1009.
  • 7The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med, 1998,339: 1349-1357.
  • 8Miller M, Cannon CP, Murphy SA, et al. Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial. J Am Coll Cardiol, 2008,51:724-730.
  • 9Sarwar N, Danesh J, Eiriksdottir G, et al. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation ,2007,115:450-458.
  • 10LaRosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med, 2005,352:1425-1435.

共引文献103

同被引文献42

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部